ANGPT2 and metabolic dysfunction-associated steatohepatitis: Lefere et al. observed higher serum Ang2 levels in patients with NASH than in patients with simple liver steatosis30, and the inhibition of Ang2 restored liver fibrosis in a NASH mouse model.